AstraZeneca’s Andrea Mugan shares her unique perspectives on patients, experience, change and challenges
Thought Leadership
Awaken the giant within
Why haven’t we been delivering more life sciences research in primary care?
Shaking it up
The partnership paradigm in clinical research
Game changer
Total-body PET imaging platform set to enhance scope of research into complex diseases and improve patient outcomes
Countdown conundrum
Producing medicines must focus on materials and net-zero, but also how we work
The time is now
Taking action for a sustainable supply chain
First service
How can pharma and med device companies support the NHS with service optimisation?
Empowering health innovation
Professor Gino Martini, CEO of the PHTA, on how Birmingham is boosting lab capacity
Is the SmPC still relevant in the digital age?
Post-pandemic, we have been forced to rethink the way in which medicines information is disseminated and consumed
Pharmaceutical labelling excellence with Epson
When it comes to the labelling for medical purposes, highly accurate labels are essential
The difference a day makes
Kate Downey talks about changing career direction and embracing patient engagement
Reality check
For the full picture ethnographic specialists Naked Eye and healthcare agency VCCP treat patients as individuals
Market forces
Mapping the next generation of life sciences talent
Orphan Drug Development
Although each individual disease is rare, their collective prevalence is estimated at around 6%-8% of the population
Just-in-time labelling
Short-term fix or long-term fixture for clinical trials?